Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

CUSIP: 005111109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
60,359,615
Total 13F shares
9,152,813
Share change
-77,615
Total reported value
$8,125,423
Put/Call ratio
0.45%
Price per share
$0.89
Number of holders
34
Value change
-$39,586
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
3/4/5 13F
Director, 10%+ Owner · Company
4.4%
from 13F
1,677,361
$2,616,683 19 Jul 2021
Shahzad Malik
3/4/5
Director
mixed-class rows
1,562,757
mixed-class rows
$2,426,946 17 Jun 2021
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
4.4%
2,651,667
$1,999,357 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
1.9%
1,140,706
$860,092 31 Mar 2023
13F
Parkman Healthcare Partners LLC
13F
Company
1.1%
653,721
$492,906 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.65%
394,800
$298,000 31 Mar 2023
13F
AMERICAN FINANCIAL GROUP INC
13F
Company
0.5%
299,995
$226,000 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0.37%
226,211
$170,562 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.31%
187,350
$141,000 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.3%
182,598
$137,678 31 Mar 2023
13F
Kamunting Street Capital Management, L.P.
13F
Company
0.3%
179,347
$135,295 31 Mar 2023
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.28%
170,100
$128,254 31 Mar 2023
13F
James F. Hinrichs.
3/4/5
Director
mixed-class rows
95,910
mixed-class rows
$119,043 16 Jun 2022
R. Scott Huennekens
3/4/5
Director
class O/S missing
529,349
$100,047 15 Jun 2023
Vincent J. Burgess
3/4/5
Chief Executive Officer, Director
class O/S missing
61,469
$95,892 01 Apr 2022
Steven McQuillan
3/4/5
SVP, Clinical Affairs & QA
class O/S missing
45,844
$71,517 01 Apr 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
79,500
$59,943 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
75,931
$57,252 31 Mar 2023
13F
Cerity Partners LLC
13F
Company
0.11%
63,698
$48,028 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.09%
56,071
$42,278 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.05%
31,438
$23,704 31 Mar 2023
13F
NICOLET ADVISORY SERVICES, LLC
13F
Company
0.05%
28,484
$19,440 31 Mar 2023
13F
AXXCESS WEALTH MANAGEMENT, LLC
13F
Company
0.04%
25,000
$18,850 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.04%
24,168
$18,222 31 Mar 2023
13F
Daniella Cramp
3/4/5
Director
mixed-class rows
31,223
mixed-class rows
$18,132 16 Jun 2022
Virtu Financial LLC
13F
Company
0.04%
24,511
$18,000 31 Mar 2023
13F
Charlie Piscitello
3/4/5
SVP, Chief People Officer
class O/S missing
85,683
$16,194 01 Apr 2023
Westside Investment Management, Inc.
13F
Company
0.03%
17,000
$12,818 31 Mar 2023
13F
Squarepoint Ops LLC
13F
Company
0.02%
12,077
$9,106 31 Mar 2023
13F
FIRST BUSINESS FINANCIAL SERVICES, INC.
13F
Company
0.02%
10,000
$7,540 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
7,694
$6,000 31 Mar 2023
13F
UBS Group AG
13F
Company
0.01%
7,166
$5,403 31 Mar 2023
13F
Belvedere Trading LLC
13F
Company
0.01%
6,900
$5,203 31 Mar 2023
13F
S.A. Mason LLC
13F
Company
0.01%
6,400
$4,826 31 Mar 2023
13F
John F. Sheridan
3/4/5
Director
class O/S missing
24,347
$4,602 15 Jun 2023
AdvisorNet Financial, Inc
13F
Company
0.01%
5,625
$4,241 31 Mar 2023
13F
Jason K. Garland
3/4/5
Director
class O/S missing
22,400
$4,234 15 Jun 2023
Niamh Louise Pellegrini
3/4/5
Director
class O/S missing
20,972
$3,964 15 Jun 2023
Andrew ElBardissi
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
David P. Bonita
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
Shaden Marzouk
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
4,836
$3,647 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0.01%
3,138
$2,366 31 Mar 2023
13F
FMR LLC
13F
Company
0%
2,053
$1,548 31 Mar 2023
13F
FEDERATED HERMES, INC.
13F
Company
0%
1,737
$1,310 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,245
$939 31 Mar 2023
13F
BAILLIE GIFFORD & CO
13F
Company
0%
424
$320 31 Mar 2023
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
250
$189 31 Mar 2023
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
101
$76 31 Mar 2023
13F
TCI Wealth Advisors, Inc.
13F
Company
0%
100
$76 31 Mar 2023
13F

Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q2 2023

As of 30 Jun 2023, Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,152,813 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Parkman Healthcare Partners LLC, RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
37
Q2 2023 holders
34
Holder diff
-3
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.